L-Arginine Extra Strength
Havasu Nutrition L-Arginine Extra Strength is a Pre-Workout supplement containing four active ingredients. It includes 400mg of L-Arginine Hydrochloride, 400mg of AAKG (Arginine Alpha-Ketoglutarate) which is at a clinical dose, 400mg of L-Citrulline Malate, and 100mg of Beet Powder. The product has an N+ Score of 76, receiving a C+ grade, signifying a good quality formulation with 100% label transparency. Its formula completeness is 33%, indicating a targeted blend rather than a comprehensive pre-workout. Research suggests these ingredients may support nitric oxide production and exercise performance. This product is suitable for individuals looking for a focused pre-workout blend.
About This Product
L-Arginine Extra Strength by Havasu Nutrition is a pre-workout supplement containing 4 active ingredients. It has earned an N+ Score of 76/100 (Grade C+).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include AAKG.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (4 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Beet powder | 100.000 mg | N/A |
| L-Citrulline Malate | 400.000 mg | N/A |
| L-Arginine Hydrochloride | 400.000 mg | N/A |
| AAKG | 400.000 mg | High |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.